Updated guidelines of reporting pharmacoeconomics and health technology assessment results from 2022 ISPOR (CHEERS 2022)
https://doi.org/10.37489/2588-0519-2022-3-4-9
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
In 2022, ISPOR released an updated checklist on economic evaluation of health care, since the latter several years have passed, the circumstances have changed, and science has progressed that it demanded fresh relevant changes. To support decision-making in accordance with the principles of evidence-based medicine, expanding participants, the involvement of as many sides as possible for more coordinated and high-quality work. The paper contains the main principles included into the ISPOR CHEERS 2022 check-list.
Keywords
рharmacoeconomics,
Updated Economic Assessment Recommendations,
Health Technology Evaluation,
ISPOR,
CHEERS
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 14.11.2022
Published: 14.11.2022
All authors have read and approved the final manuscript.
Peer review info:
"Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Authors
M. A. Truuts
Federal State Budgetary Educational Institution of Higher Education “Academician I.P. Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation
Russian Federation
Russian Federation
Truuts Marina A., Assistant of professor Department of Clinical Pharmacology and Evidence-Based Medicine
Saint-Petersburg
A. A. Kurilev
Federal State Budgetary Educational Institution of Higher Education “Academician I.P. Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation; NMRC of Oncology named after N.N. Petrov of MoH of Russia
Russian Federation
Russian Federation
Kurilev Aleksey A., Assistant of professor Department of Clinical Pharmacology and Evidence-Based Medicine
Saint-Petersburg
SPIN code: 4470-7845
A. S. Kolbin
Federal State Budgetary Educational Institution of Higher Education “Academician I.P. Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation; State Budgetary Educational Institution of Higher Education “Saint-Petersburg State University”
Russian Federation
Russian Federation
Kolbin Alexey S., Dr. Sci. (Med.), Professor, Head of the Department of Clinical Pharmacology and Evidence-Based Medicine; Professor of the Department of Pharmacology of the Faculty of Medicine
Saint-Petersburg
SPIN code: 7966-0845
References
1. Ocenka medicinskih tekhnologij. Ed by: Belousov YuB. Moscow: Izdatel'stvo OKI, 2013. (In Russ). URL: https://izdat-oki.ru/ocenka-medicinskih-tehnologij-rekomendacii.
2. Avxentyeva MV, Omelyanovsky VV. Perspectives of Health Technology Assessment in the Russian Federation. “Doctor.Ru” Internal Medicine. Clinical Sleep Medicine. 2015;(3 (104) - 4 (105)):12-6. (In Russ).
3. Health Technology Assessment (HTA) Glossary. INAHTA, 2006. URL: http://www.inahta.net.
4. Kliniko-ekonomicheskij analiz (ocenka, vybor medicinskih tekhnologij i upravlenie kachestvom medicinskoj pomoshchi) / MA Avksentiev, VB Gerasimov, MV Sura; Ed by PA Vorobyov. Moscow: N'yudiamed, 2004. (In Russ).
5. International Society for Pharmacoeconomics and Outcomes Research, The Professional Society for Health Economics and Outcomes Research. URL: https://www.ispor.org.
6. Husereau D, Drummond M, Augustovski F, et al.; CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for HealthEconomic Evaluations. Value Health. 2022 Jan;25(1):3-9. https://doi.org/10.1016/j.jval.2021.11.1351
7. Husereau D, Drummond M, Petrou S, et al.; ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013 Mar-Apr;16(2):231-50. https://doi.org/10.1016/j.jval.2013.02.002
8. Vklyuchenie lekarstvennykh preparatov v ogranichitel'nye perechni: poshagovyi algoritm / pod obshch. red. Belousova D. Yu., Zyryanova S. K., Kolbina A. S. - M. : Izdatel'stvo OKI : Buki Vedi, 2019. - 252 s. : il. - ISBN 978-5-4465-2555-3.
Review
For citations:
Truuts M.A., Kurilev A.A., Kolbin A.S. Updated guidelines of reporting pharmacoeconomics and health technology assessment results from 2022 ISPOR (CHEERS 2022). Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2022;(3):4-9. (In Russ.) https://doi.org/10.37489/2588-0519-2022-3-4-9
Views:
1073
ISSN 2588-0519 (Print)
ISSN 2618-8473 (Online)
ISSN 2618-8473 (Online)
Email this article 